Microbiota, gastrointestinal infections, low-grade inflammation, and antibiotic therapy in irritable bowel syndrome (IBS): an evidence-based review

Microbiota, gastrointestinal infections, low-grade inflammation, and antibiotic therapy in irritable bowel syndrome (IBS): an evidence-based review

Background: Post-infectious irritable bowel syndrome (PI-IBS) prevalence, small intestinal bacterial overgrowth (SIBO), altered microbiota, low-grade inflammation, and antibiotic therapy in IBS are all controversial issues. Aims: To conduct an evidence-based review of these factors. Methods: A revie...

Full description

Bibliographic Details
Main Authors: Max Schmulson, María Victoria Bielsa, Ramón Carmona-Sánchez, Angélica Hernández, Aurelio López-Colombo, Yolanda López Vidal, Mario Peláez-Luna, José María Remes-Troche, José Luis Tamayo, Miguel Angel Valdovinos
Format: Article
Language:English
Published: Elsevier 2014-04-01
Series:Revista de Gastroenterología de México (English Edition)
Subjects:
Irritable bowel syndrome
Bacterial overpopulation
Post-infectious
Microbiota
Low-grade inflammation
Antibiotic treatment
Rifaximin
Adults
Children
Evidence-based review
Mexico
Online Access:http://www.sciencedirect.com/science/article/pii/S2255534X14000218

Internet

http://www.sciencedirect.com/science/article/pii/S2255534X14000218

Similar Items